Thyroid hormone receptors (TRs) are ligand-regulatable transcription factors.
Introduction
Thyroid hormone receptors (TRs) belong to a super family of transcription factors that include the retinoic acid, steroid, vitamin D, and peroxisomal proliferator activator receptors (McKenna et al., 1999; Yen, 2001 ). There are two major TR isoforms, TRα and TRβ. TRs bind to thyroid hormone response elements (TREs) in the promoters of target genes and regulate their transcription. In the absence of hormone, TRs bind to corepressors such as nuclear receptor co-repressor (NCoR) or silencing mediator for retinoic and thyroid hormone receptors (SMRT), and repress basal transcription by recruiting of histone deacetylases, and modifying chromatin structure . In the presence of T 3 , co-repressor complexes are released from TRs, and co-activator complexes are recruited, leading to increased local histone acetylation and transcriptional activation.
TRs play a vital role during embryonic development and metamorphosis (Sachs et al., 2002) , and it has been suggested that TR recruitment of co-repressors may be a means for suppressing gene expression during metamorphosis. T 3 also has been shown to be mitogenic and is required for cell growth and development in certain cell lines (DeFesi et al., 1984; Humes et al., 1992; Quintanar-Stephano and Valverde, 1997; Di Fulvio et al., 2000) . Additionally, T 3 can regulate cell proliferation and differentiation (Robson et al., 2000; Miura et al., 2002) . Recently, it has been shown that human TRβ1 interacts with p53, a tumor suppressor, which plays a critical role in cell cycle regulation and tumorigenesis (Yap et al., 1996) . TR binding to p53 leads to decreased p53-dependent induction of bax and gadd45 expression but does not affect the expression of p21; suggesting TR can differentially modulate p53-target genes (Barrera-Hernandez et al., 1998) . This cross talk between two cell-signaling pathways could play an important role in both normal and transformed cells. In this connection, mutant thyroid hormone receptors with defective function have been found in hepatocellular, renal clear cell, and thyroid cancers as well as thyrotropin-secreting pituitary tumors (Lin et al., 1996; Ando et al., 2001; Kamiya et al., 2002) .
Previous studies suggest that T 3 -binding activity changes during the cell cycle; however, these early studies did not directly examine TR mRNA or protein expression during the cell cycle (DeFesi et al., 1982; Surks and Kumara-Siri, 1984; Kumara-Siri and Surks, 1985; Kumarasiri et al., 1988) . Glucocorticoid receptor expression and hormone sensitivity also varies during different stages of the cell cycle (Hsu et al., 1992; Hsu and B, 1995) . Moreover, the anti-proliferative effects of the estrogen receptor antagonist, tamoxifen, change in a cell cycle-dependent manner in MCF-7 cells (Dong et al., 1991; Dong et al., 1992) . Recently, we used confocal microscopy to study the nucleocytoplasmic shuttling and intranuclear distribution of TRs and other nuclear hormone receptors (NRs) in HeLa cells transfected with vectors expressing green fluorescent protein-NR chimeras. We observed an energy-dependent nuclear uptake of NRs as well as an intranuclear redistribution of NRs upon ligand addition (Baumann et al., 2001; Maruvada et al., 2003) . Currently, there is little information on the intranuclear expression or distribution of NRs during the cell cycle. To address this issue, we established a permanently-transfected cell line expressing GFPTR and used laser scanning cytometry (LSC) to observe that TR expression and distribution, as well as transcriptional activity, changes during different stages of the cell cycle. Our data thus provide new insights into some of the cellular and molecular events that account for variable hormone sensitivity by NRs during the cell cycle.
Materials and Methods

Plasmids and vectors
Rat TRβ was cloned as a green fluorescent protein fusion into TRE vector (Clontech, Palo Alto CA). Briefly TRE vector was restriction digested with Sac II and then filled in with klenow fragment followed by treatment with Eco RI, while the GTR was cut with Eco 47 III and EcoRI and ligated with TRE vector.
Stable cell lines
HeLa -Teton cells were transfected with GFPTR-TRE vector and the clones were selected for hygromycin B resistance marker. The clones were finally selected by FACS sorting for positive GFP expressing cells in the presence of doxycycline (2.5 µg/mL). The stable cells were regularly maintained in DMEM with 10% FBS and antibiotics (100 U/ml penicillin and streptomycin, 0.5 mg/ml gentamycin; 0.1 mg/ml) G418 and 0.3-mg/ml hygromycin B as resistance markers (GIBCO BRL Gaithersburg MD) and lglutamine, 2 mM in 5% CO 2 incubator at 37 0 C.
Cell Cycle Synchronization
Exponentially growing cells on cover slips were synchronized by the addition of hydroxyurea (2mM final conc.) (Sigma, St Louis MO) for 16 hrs at early S-phase and released them into S-phase by the addition of fresh medium without hydroxy urea and in the presence of Doxycycline (Sigma, St Louis MO). Cells were harvested at specified time intervals and processed for LSC, confocal microscopy or analyzed proteins by western blotting.
Laser scanning cytometry (LSC)
Cells were fixed with 100% methanol at -20 0 C for 30 min. The fixed cells were washed with PBS three times, permeabilized with 0.1% Triton X100 for 10' followed by RNAse (1 mg/ml) (Roche, New York NY) treatment for 15' at RT. Finally the cells were treated with propidium iodide (10 µg/ml) (Sigma, St Louis MO) for 5 min. and then mounted with 150 µl of antifade (Molecular Probes, Inc, Eugene OR.). The cell cycle was analyzed by a laser scanning cytometer (Compucyte Corp., Cambridge MA) by measuring the total PI fluorescence and the peak intensity of fluorescence in the cell nuclei (Dmitrieva et al., 2000; Dmitrieva et al., 2001) . Total nuclear PI fluorescence is the integral of fluorescence calculated over the entire area of a nucleus and corresponds to DNA content. GFP-TRβ expression was measured in the FITC channel with 15% laser and the total FITC fluorescence and the peak intensity were measured. A gate representing the approximate limit of peak fluorescence in cells with negligible GFPTR expression was determined by visual inspection. The data were displayed as bivariate cytograms, plotting peak green fluorescence versus total PI fluorescence in nucleus or particle to determine the number of GFPTR positive cells (representative cytogram is shown on Fig 3A) . For cell cycle distribution analysis the data were plotted as histograms showing amount of cells with different DNA content (Fig. 2) . by confocal microscopy and images in both FITC and PI channels were collected simultaneously using TCS NT software and processed by Adobe Photoshop 6.0.
Western blot analysis
HeLa -Tet-on cells or GH3 were synchronized with hydroxyurea for 16 hrs and released into cell cycle progression by adding fresh medium. The cells were harvested at 2 hr time intervals and the isolated proteins analyzed by western blotting using anti-TRβ antibody (Affinity Bioreagents, Golden, CO) followed by horse radish peroxidase-tagged secondary antibody and detected by ECL method. For treatment with cycloheximide, the cells were treated with cycloheximide (50 µg/mL) for specified time intervals and the cells were harvested and proteins were analyzed by western blotting.
RT-PCR analyses
Total RNA was isolated from synchronized and released HeLa-Tet-on cells and analyzed by RT-PCR using primers specific for TRβ1 (Baumann et al.) Results
Doxycycline (Dox) dependent expression of GFPTR
The dose-dependent expression of GFPTR by doxycycline, a stable analog of tetracycline, was observed by LSC ( Fig. 1 ). In the absence of doxycycline, there were less than 1% cells expressing GFPTR indicating the Tet-On system was tightly-regulated in an antibiotic-specific manner. As the concentration of doxycycline increased, there was a dose-dependent increase in GFPTR-expressing cells, which reached maximal levels at 2.5-5.0 µg/ml, beyond which the % expressing cells declined due to antibiotic toxicity. On the basis of these data, all subsequent studies were conducted at 2.5 µg/ml concentration of doxycycline. Of note, only 5-10% of the cell population expressed GFPTR even in the presence of optimal concentrations of doxycycline. The mechanism for this limited expression is not known; however, it is possible that cell cycle-dependent differences in GFPTR expression could potentially account for the limited expression within the cell population of the GFPTR clonal cell line.
Cell cycle analysis of HeLa-GFPTR cell line
To examine this possibility, GFPTR cells were synchronized with hydroxyurea for 16 hrs and released into the cell cycle by the addition of fresh medium without hydroxyurea. Cells then were harvested and sorted according to their cell cycle phase by LSC (Fig. 2) . The majority of non-synchronized cells was in G 1 phase, and appeared as a major peak on the cytogram (Fig. 2a) . When the cells were synchronized with hydroxyurea, they were arrested at the beginning of S phase and appeared as one peak (Fig. 2b ). They then progressed into S phase after two hours as the peak shifted towards the right (Fig. 2c) . After 10 hours, a major G 2 peak appeared in the cytogram (Fig. 2d) indicating that most of the cells were in the G 2 /M phase of the cell cycle. After 12 hours, there were two nearly equal populations of G 1 and G 2 /M observed on the cytogram (Fig.   3e ). Cells finally completed one round of the cell cycle after approximately 14 hours ( Fig. 3f ). Addition of T 3 did not change the progression of these cells through the cell cycle (data not shown).
Cell cycle-dependent expression of GFPTR
The expression of GFPTR under synchronized conditions was studied using markers for different stages of the cell cycle (Fig. 4) . More than 90% of the cell population was in S phase 2 hours after release as determined by BrdU staining, which then decreased to less than 10% 6 hours afterwards (squares). Phosphohistone staining (marker for mitosis) increased after 6 hrs and peaked at 12 hrs indicating that most cells were in mitosis during this time (triangles). Interestingly, GFPTR expression increased at 4 hours and peaked at 8 hours and before decreasing to less than 10% at 14 hours (diamonds). In conjunction with 
GFPTR is not expressed during S phase
To determine whether GFPTR is expressed in S phase, immunofluorescence studies were performed on GFPTR cells with anti-BrdU antibodies, which specifically stain cells in S phase of the cell cycle. Under these conditions, there was no concomitant green fluorescence with BrdU staining indicating that GFPTR was not expressed in S phase (Fig. 4a, b) . DNA counter-staining also was performed with DAPI ( Fig. 4c) .
GFPTR is expressed in early mitosis
The expression of GFPTR was studied along with, immunofluorescent staining with anti-phosphohistone antibody, which stains for mitotic cells. Prophase cells had both positive phosphohistone staining and GFPTR expression (Fig. 5a, b) . Interestingly, both metaphase and anaphase cells did not express GFPTR to any significant extent (Fig. 5d , e, g, and h). These findings suggest that GFPTR expression disappeared between prophase and metaphase. Additionally, intranuclear GFPTR was expressed along the nuclear membrane in prophase, in contrast to the more diffuse, homogenous pattern observed in G 2 . These findings demonstrate cell cycle-dependent redistribution of TRs.
DNA counter-staining with DAPI (Fig. 5c , f and i) confirmed the immunofluorescent staging of the cells.
Transactivation by GFPTR during G 2 block
We examined whether T 3 -mediated transcriptional activity could be modified during the cell cycle by changes in TR expression levels. Accordingly, the transactivation by GFPTR was studied by synchronizing the cells in G 2 and transfecting a TRE luciferase reporter gene into the GFPTR cell line. We previously showed that GFPTR had similar T 3 -mediated transcriptional activity as wild-type TRβ in co-transfection studies (Baumann et al., 2001) . The cells were synchronized with hydroxyurea after 24 hrs and released into S phase by adding fresh medium. When the cells were about to reach the G 2 /M phase, they were blocked with nocodazole, which inhibits cell mitosis. Under these conditions the transcriptional activity of GFPTR was studied in the presence and absence of T 3 by analyzing the luciferase activity in the lysates after 24 hrs. As shown in Fig. 6 , the T 3 -mediated transcriptional activity was further increased by almost 2-fold, suggesting that increased transcriptional activity occurred when GFPTR expression was maximal.
Post-transcriptional regulation of GFPTR expression
The increased expression of GFPTR during G 2 phase of the cell cycle could be due to increased mRNA expression and/or increased protein synthesis. To determine the cause for increased GFPTR expression, we studied the protein expression of GFPTR by
Western blot analysis and its mRNA expression by RT-PCR (Fig. 7) . Protein expression patterns were similar to those obtained by LSC, and thus provided further evidence for cell cycle changes in TR expression (Fig. 7a) . However, there was no significant change in the mRNA expression (Fig. 7b) . Taken together, these findings suggest that posttranscriptional changes primarily regulate the expression of GFPTR during the cell cycle.
Western blotting analysis also was performed on extracts of GH 3 cells, which express endogenous TRβ. Endogenous TRβ expression was low during S phase and increased during G 2 (Fig. 8) . Thus, the endogenous TRβ expression pattern during the cell cycle in GH 3 cells was similar to that observed in GFPTR cells. In both Figs. 7 and 8, the TRβ protein levels were low at time 0 as the majority of cells were in G1 phase and
TRβ is not significantly expressed during this phase (see Figs. 2, 3) . Additionally, as observed in Fig. 7 , we did not observe significant changes of endogenous TRβ mRNA expression during the GH 3 cell cycle (unpublished results).
New protein synthesis required for GFPTR expression
The increased GFPTR protein expression may be due to increased protein synthesis or decreased protein degradation, or a combination of both these processes. In order to determine whether new protein synthesis is required for the increased levels of GFPTR during the cell cycle, cells were treated with cycloheximide 4 hours after release, and their expression determined by both Western blot analysis ( Fig. 9A ) and LSC (9B).
These results suggest that increased GFPTR expression is primarily due to increased translation.
Discussion
Our studies demonstrate that TR expression varies according to the cell cycle.
From cell synchronization studies, we observed virtually no expression of TR in early S phase, but a progressive increase in its expression during late S and G 2 until maximal levels were reached at G 2 /M. TR was expressed during prophase of mitosis but then disappeared during anaphase and telophase. It reappeared at low levels during G 1 .
Similar patterns were observed in Western blots of TRβ in GFPTR and GH 3 cells (the latter which contains endogenous TRs). The transcriptional activity in response to T 3 also varied during the cell cycle and correlated with TR expression.
Previous studies with GR and TR showed increased hormone binding in S phase and G 2 (Surks and Kumara-Siri, 1984 ) (Cidlowski and Cidlowski, 1982; Filipcik et al., 1992 The mechanism for the increased TR expression during G 2 is likely due to posttranscriptional mechanisms as mRNA levels were stable while TR proteins levels increased. The blockade of the increase in TR protein expression by cycloheximide suggests that translational regulation is critically important for TR expression during this stage of the cell cycle. Since only the TRβ1cDNA was used in the GFP construct, translational regulation cannot occur via the 5' or 3' UTR of TRβ1 mRNA. Recently, several examples of translational regulation by proteins that bind to the coding sequence of mRNAs have been described (Spencer and Eberwine; Xu and Grabowski, 1999 (Koibuchi and Chin, 2000) . Also, TH plays critical roles during important stages of embryogenesis and metamorphosis (Su et al., 1999) .
Additionally, it is possible that the particular cell cycle composition in a given tissue may contribute towards the tissue response in pathological states of hormone excess such as the syndrome of resistance to thyroid hormone (Yen, 2003) .
Although receptor expression often correlates with transcriptional responsiveness to hormone (Nyborg et al., 1984; Yaffe and Samuels, 1984) , other processes must be involved, as increased expression of ER or GR per se, does not invariably lead to increased transcription or cell progression (Darbre and King, 1987; Planas-Silva et al., 1999) . The competency of NRs to respond to hormones in a given cell may require other effects, some of which may be cell cycle-specific, such as phosphorylation of receptors, expression of co-activators, or DNA methylation or histone modifications of target genes (Hsu and B, 1995; Garcia-Villalba et al., 1997; Planas-Silva et al., 2001; Berger and Daxenbichler, 2002) We and others previously have shown that NRs are dynamic as they shuttle between the cytoplasm and nucleus, rapidly diffuse within the nucleus, continously exchange between the DNA enhancer elements, and change their intranuclear distribution in response to hormone (McNally et al., 2000; Baumann et al., 2001; Bunn et al., 2001; Maruvada et al., 2003) . Our present studies show that not only does the expression of TRs vary during the cell cycle, but TRs also can redistribute during the cell cycle as intranuclear TR changes from a diffuse homogeneous pattern in G 2 to a peripheral pattern within the nucleus during anaphase. The mechanism and purpose of this change in intranuclear distribution of TR currently is not known but may be due to association with insoluble nuclear components (Baumann et al., 2001; Stenoien et al., 2001; Reid et al., 2003) . Recently, several laboratories have noted cyclical recruitment of nuclear hormone receptors and co-factors to hormone response elements in chromatin immunoprecipitation (ChIP) assays, although the timing and periodicity can vary (Brown et al., 1995; Sharma and Fondell, 2000; Reid et al., 2003) . Although some of these observed effects may be due to differences in the cell types used in these studies, it also is possible that cell cycle differences may contribute to this variability, particularly given our present findings.
In summary, we have observed cell cycle-dependent changes in TR expression and distribution, which in turn, can affect transcriptional response to T 3 . These novel observations of cell cycle-dependent effects on TR expression may occur for other nuclear hormone receptors. Furthermore, they suggest that differential hormone sensitivity may occur during the cell cycle, and thus contribute to hormonal effects in cell cycle progression during normal development and oncogenesis. . Post-transcriptional regulation of GFPTR expression. GFPTR stable cells were synchronized with hydroxyurea for 16 hrs. At the end of synchronization, cells were washed with PBS and fresh medium alone added. The cells were harvested at 2 hr intervals and protein and RNA were isolated. A) TR expression was detected by Western blotting analysis, using anti-TRβ1 antibodies, followed by treatment with HRPO-labeled secondary antibodies and ECL as described in Materials and Methods. The band intensities are plotted as a bar graph. B) TR mRNA expression was detected by RTPCR amplified to 20 cycles, using appropriate oligonucleotides. Figure 8 . Cell cycle-dependent expression of TRβ in GH3 cells. GH3 cells were synchronized with hydroxyurea for 16 hrs. At end of the block, cells were washed and fresh medium added. The cells were harvested at 2 hr intervals and the protein was isolated. TR expression studied by Western blotting analysis, using anti-TRβ1 antibody followed by treatment with HRPO-labeled secondary antibodies and detection by ECL.
The band intensities were plotted in a bar graph. Figure 9 . New protein synthesis required for GFPTR expression. GFPTR-expressing cells were synchronized with hydroxyurea for 16hrs. At the end of the block, the cells were washed with PBS and fresh medium. 4 hrs after release, cells were treated with 50−µg/ml cycloheximide and either fixed or harvested for protein at 1/2, 1, 2 and 4 hrs after release. A) TRβ protein expression detected by Western blotting. B) The % cells expressing GFPTR was analyzed by LSC. 
